Hims & Hers (NYSE: HIMS) has put investors on a roller coaster ride in 2025. *Stock prices used were the afternoon prices of ...

Hims & Hers continues to deliver strong subscriber and revenue growth, with Q1 2025 revenue up 111% YoY. Check out why I ...

We recently published a list of 10 Surprising Stocks That Skyrocketed Today. In this article, we are going to take a look at ...

Analysts at Citi and Bank of America are maintaining a cautious stance on Hims & Hers Health as competition in the GLP-1 space intensifies and growth begins to moderate.

Hims & Hers leads with AI-powered, personalized health plans (over 70% of new users opt in). Recurring revenues surge as ...

Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...

Hims & Hers plans to expand its women's health services and sees the category "likely eclipsing" the men's business, Chief ...

Online health and wellness company Hims & Hers raised $1 billion through convertible senior notes to grow its international ...

CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.

Hims & Hers Health HIMS is well-positioned for growth as it addresses a vast unmet healthcare market, leveraging a total addressable market of $360M across specialties like mental health ...